140 related articles for article (PubMed ID: 25631836)
1. Economic burden of recurrent venous thromboembolism: analysis from a U.S. hospital perspective.
Casciano JP; Dotiwala Z; Kemp R; Li C; Cai J; Preblick R
Am J Health Syst Pharm; 2015 Feb; 72(4):291-300. PubMed ID: 25631836
[TBL] [Abstract][Full Text] [Related]
2. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
Lin J; Lingohr-Smith M; Kwong WJ
J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
[TBL] [Abstract][Full Text] [Related]
3. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
[TBL] [Abstract][Full Text] [Related]
4. Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.
LaMori JC; Shoheiber O; Mody SH; Bookhart BK
Clin Ther; 2015 Jan; 37(1):62-70. PubMed ID: 25524389
[TBL] [Abstract][Full Text] [Related]
5. Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US.
Amin A; Deitelzweig S; Bucior I; Lin J; Lingohr-Smith M; Menges B; Neuman WR
J Med Econ; 2019 Nov; 22(11):1119-1125. PubMed ID: 31084383
[No Abstract] [Full Text] [Related]
6. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
[TBL] [Abstract][Full Text] [Related]
7. National trends in hospitalizations for venous thromboembolism.
Brahmandam A; Abougergi MS; Ochoa Chaar CI
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):621-629.e2. PubMed ID: 28818212
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates.
Mahan CE; Borrego ME; Woersching AL; Federici R; Downey R; Tiongson J; Bieniarz MC; Cavanaugh BJ; Spyropoulos AC
Thromb Haemost; 2012 Aug; 108(2):291-302. PubMed ID: 22739656
[TBL] [Abstract][Full Text] [Related]
10. Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States.
Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
J Manag Care Spec Pharm; 2015 Oct; 21(10):965-72. PubMed ID: 26402395
[TBL] [Abstract][Full Text] [Related]
11. Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer.
Khorana AA; McCrae KR; Milentijevic D; Laliberté F; Lejeune D; Crivera C; Lefebvre P
J Med Econ; 2020 Apr; 23(4):323-329. PubMed ID: 31818164
[No Abstract] [Full Text] [Related]
12. All-cause and disease-related health care costs associated with recurrent venous thromboembolism.
Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Hossou Y; Schein J; Kaatz S
Thromb Haemost; 2013 Dec; 110(6):1288-97. PubMed ID: 24085327
[TBL] [Abstract][Full Text] [Related]
13. Rate and impact of venous thromboembolism in patients with ST-segment elevation myocardial infarction: Analysis of the Nationwide Inpatient Sample database 2003-2013.
Al-Ogaili A; Ayoub A; Diaz Quintero L; Torres C; Fuentes HE; Fugar S; Kolkailah AA; Dakkak W; Tafur AJ; Yadav N
Vasc Med; 2019 Aug; 24(4):341-348. PubMed ID: 30915913
[TBL] [Abstract][Full Text] [Related]
14. Cost of venous thromboembolism in hospitalized medically ill patients.
Pendergraft T; Atwood M; Liu X; Phatak H; Liu LZ; Oster G
Am J Health Syst Pharm; 2013 Oct; 70(19):1681-7. PubMed ID: 24048605
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
[TBL] [Abstract][Full Text] [Related]
16. Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients.
Knight KK; Wong J; Hauch O; Wygant G; Aguilar D; Ofman JJ
Value Health; 2005; 8(3):191-200. PubMed ID: 15877591
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
18. Trends and Outcomes of Venous Thromboembolism in Hospitalized Patients With Ovarian Cancer: Results From Nationwide Inpatient Sample Database 2003 to 2011.
Mittal V; Ahuja S; Vejella SS; Stempel JM; Palabindala V; Dourado CM; Leighton JC
Int J Gynecol Cancer; 2018 Oct; 28(8):1478-1484. PubMed ID: 30045139
[TBL] [Abstract][Full Text] [Related]
19. Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients.
Ollendorf DA; Vera-Llonch M; Oster G
Am J Health Syst Pharm; 2002 Sep; 59(18):1750-4. PubMed ID: 12298113
[TBL] [Abstract][Full Text] [Related]
20. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.
Baser O; Supina D; Sengupta N; Wang L; Kwong L
Am J Health Syst Pharm; 2010 Sep; 67(17):1438-45. PubMed ID: 20720243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
